PHTD 2012 Spring Meeting - units.sla.org

More documents

Recommendations

Info

PHTD 2012 Spring Meeting, Baltimore MD 30 Adis BizInt Solutions Please visit our sponsors in the Exhibit Hall during the Opening Reception and during breakfast, breaks and lunch on Monday and Tuesday. Diamond Sponsors Adis has a 40-year heritage of offering valuable information in pharmacology, therapeutics and disease management. Journals published by Adis cover all aspects of drug development from bench to bedside. Adis journals are a must-have resource for anyone working or studying in drug therapy and pharmacology. AdisInsight databases provide decision support tools that produce valuable insight into global drug development, clinical trials, and drug safety. Accurate, timely, and comprehensive information is the cornerstone on which AdisInsight databases are built. Adis R&D Insight is a leading drug pipeline database that tracks and evaluates drugs worldwide through the entire development process. It provides detail scientific review and forward looking commercial analysis for market and competitive analysis. Adis Clinical Trials Insight is the only clinical trials database to provide quick access to ongoing trials from internet trial registries as well as trial results presented at medical conferences and published in scientific journals. This approach provides complete information to assess competitor studies, identify treatment gaps, and make strategic decisions. Ask the Expert service provides you access to our editorial team to insure you get the insights you need. This service is included free with all AdisInsight database subscriptions. BizInt Solutions, Inc. is a small software company based in southern California. We develop, market and support the BizInt Smart Charts software products — including BizInt Smart Charts for Patents, BizInt Smart Charts for Drug Pipelines, and BizInt Smart Charts Reference Rows — which help information specialists create, customize, update and distribute tabular reports combining data from the leading patent and drug pipeline databases. Our customers include pharmaceutical, biotech, chemical, petroleum, and device manufacturing companies in North America and Europe. To learn about the latest features or to download a free, fully functional trial copy of our BizInt Smart Charts products visit our website: www.bizcharts.com.
Elsevier Elsevier Business Intelligence As the world’s leading provider of science and health information, Elsevier serves more than 30 million scientists, students and health and information professionals worldwide. We help customers advance science and health by providing world-class information and innovative tools that help them make critical decisions, enhance productivity and improve outcomes. In short, Elsevier’s information solutions increase the value of content and empower you to accelerate scientific research Elsevier Business Intelligence (EBI), a global leader in the field of healthcare industry information, provides business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, e-learning, databases and reports, Elsevier Business Intelligence places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis. EBI has amassed an unparalleled number of personal contacts at most companies in the pharmaceutical, biotech, medical device and diagnostic industries as well as in the investment banking, venture capital, consulting and other industry-support sectors. Our editorial and research staff leverages this extensive contact list in primary research, which we supplement with extensive scanning, an understanding and a use of company and SEC documents. But, whereas other information providers merely parrot back what they learn, EBI’s editors and writers use their extensive expertise in the industry to draw out the significance of the data, presenting not merely the facts but what we call the “so what” of trends, events, and strategies. Visit us at www.ElsevierBI.com. New England Journal of Medicine Diamond Sponsors The New England Journal of Medicine is pleased to offer corporate customers global, organization-wide access to its premier content. In addition to our standard license, which includes content back to 1990; we now offer access to the NEJM Archive. The NEJM Archive is available in two tiers: 1945-1989 and 1812-1944. Year after year, week after week, NEJM publishes groundbreaking research on the cutting edge of medicine. The NEJM corporate site license offers access via IP-authentication to enable your physician researchers, regulatory personnel, product managers, and sales staff seamless access to all NEJM content through your corporate network right from their desktops. 31
Page 1 and 2: Photos courtesy of Visit Baltimore
Page 3 and 4: SLA Pharmaceutical & Health Technol
Page 5 and 6: Contents Table of Contents Agenda i
Page 7 and 8: Applying text mining techniques for
Page 9 and 10: Opening Keynote: The US Pharmaceuti
Page 11 and 12: Practical steps to reinvent the Cor
Page 13 and 14: Managing data and providing competi
Page 15 and 16: Mobile Devices & the Information Pr
Page 17 and 18: Librarians as internal consultants
Page 19 and 20: KOLs - who are they, where are they
Page 21 and 22: Utilizing OvidSP and QUOSA for AdCo
Page 23 and 24: The Rise of China: Implications for
Page 25 and 26: Biosimilars and biopharmaceuticals
Page 27 and 28: Vendor Panel - Discovery Services w
Page 29 and 30: Breakout Sessions Tuesday PM Speake
Page 31: Breakout Sessions - Summaries Tuesd
Page 35 and 36: Platinum Sponsors BioCentury Public
Page 37 and 38: EvaluatePharma FirstWord EvaluatePh
Page 39 and 40: Infotrieve, Inc. Leadership Directo
Page 41 and 42: PMR SAGE PMR is a research, consult
Page 43 and 44: Wiley-Blackwell Gold Sponsors Wiley
Page 45 and 46: Linguamatics Logicden Linguamatics
Page 47 and 48: Technology & Patent Research Intern
Page 49 and 50: PHTD 2011 Spring Meeting, Orlando F
Page 51 and 52: Diamond Sponsors - Ads CONNECTING M
Page 53 and 54: OvidSP Join Ovid at the 2012 SLA P&
Page 55 and 56: Visit Citeline’s booth in the exh
Page 57 and 58: Here, the curious Discover. Validat
Page 59 and 60: Platinum Sponsors - Ads Welcome to
Page 61 and 62: FOI Services: Unpublished FDA Infor
Page 63 and 64: For your desktop, laptop and iPad
Page 65 and 66: Platinum Sponsors - Ads Biotech/Bio
Page 67 and 68: Platinum Sponsors - Ads pharmaceuti
Page 69 and 70: SAGE Premier is an invaluable inves
Page 71 and 72: “ Tarius is our no. 1 regulatory
Page 73 and 74: Platinum Sponsors - Ads 71
Page 75 and 76: Attendees (cont.) Name Company Emai
Page 77 and 78: Sponsor Attendees (sorted by compan
Page 79 and 80: 2012 Officers and Board Members Cha

PHTD 2012 Spring Meeting - units.sla.org

Create successful ePaper yourself

Delete template?

Save as template?